S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer |
Anxiety Questionnaire Administration, Quality-of-Life Assessment, Serum Tumor Marker directed disease monitoring, Usual care disease monitoring |
Recruiting |
Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico |
Biopsy, Biospecimen Collection - Anal, Biospecimen Collection - Cervical, Colposcopy, High Resolution Anoscopy, Imaging Technique |
Recruiting |
Screening Strategies for People With a High Risk of Anal Cancer |
Anal Cytology, CINtec®PLUS, Genotyping of anal hrHPV infection, HRA + Biopsy |
Recruiting |
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia |
Laboratory Biomarker Analysis, Simplified Patient Care Strategy |
Active, not recruiting |
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis |
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Placebo Administration, Questionnaire Administration, Simvastatin |
Active, not recruiting |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Sargramostim |
Recruiting |
Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) |
Placebo, Vitamin E Delta Tocotrienol |
Active, not recruiting |
Study of Kidney Tumors in Younger Patients |
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis |
Active, not recruiting |
Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer |
Apalutamide, Biopsy Procedure, Biospecimen Collection, Placebo Administration, Questionnaire Administration, Transurethral Resection of Bladder Tumor |
Not yet recruiting |
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation |
Denosumab, Placebo, Quality-of-Life Assessment |
Active, not recruiting |